NCT05780424

Brief Summary

This study looks at the safety and effectiveness of BRII-196/BRII-198 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either BRII-196/BRII-198 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H3.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
353

participants targeted

Target at P25-P50 for phase_3 covid19

Timeline
Completed

Started Dec 2020

Longer than P75 for phase_3 covid19

Geographic Reach
8 countries

107 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 16, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 8, 2021

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 20, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 22, 2023

Completed
11 months until next milestone

Results Posted

Study results publicly available

February 5, 2024

Completed
Last Updated

February 5, 2024

Status Verified

February 1, 2024

Enrollment Period

6 months

First QC Date

March 20, 2023

Results QC Date

January 8, 2024

Last Update Submit

February 2, 2024

Conditions

Keywords

COVID-19COVID 19Coronaviridae InfectionsCoronavirus InfectionsRNA Virus InfectionsVirus InfectionsNidovirales InfectionsSARS-CoV-2SARS CoronavirusACTIV-3ACTIV3TICO

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With an Ordinal Outcome on Day 5

    Ordinal outcome with 7 mutually exclusive categories

    Status on Day 5

Secondary Outcomes (4)

  • Number of Participants Who Died From All Causes

    Through Day 90

  • Number of Participants With a Safety Outcome Through Day 5

    Through Day 5

  • Number of Participants With a Safety Outcome Through Day 28

    Through Day 28

  • Number of Participants With a Safety Outcome Through Day 90

    Through Day 90

Study Arms (2)

BRII-196/BRII-198 plus SOC

EXPERIMENTAL

* BRII-196 1000 mg solution; administered as IV infusion * BRII-198 1000 mg solution; administered as IV infusion * Remdesivir is provided to all study participants as SOC unless contraindicated for an individual patient; administered by IV infusion

Biological: BRII-196Biological: BRII-198Biological: Remdesivir

Placebo plus SOC

PLACEBO COMPARATOR

* Placebo administered by IV infusion * Remdesivir is provided to all study participants as SOC unless contraindicated for an individual patient; administered by IV infusion

Biological: PlaceboBiological: Remdesivir

Interventions

BRII-196BIOLOGICAL

BRII-196 is a fully human immunoglobulin G (IgG)-1 monoclonal antibody (mAb) derived from antibody P2C-1F11 that was isolated directly from human B cells of a convalescent COVID-19 patient.

BRII-196/BRII-198 plus SOC
BRII-198BIOLOGICAL

BRII-198 is a fully human IgG-1 mAb derived from antibody P2B-1G5 that was isolated directly from human B cells of a convalescent COVID-19 patient.

BRII-196/BRII-198 plus SOC
PlaceboBIOLOGICAL

Commercially available 0.9% sodium chloride solution

Placebo plus SOC
RemdesivirBIOLOGICAL

Antiviral agent

Also known as: Veklury
BRII-196/BRII-198 plus SOCPlacebo plus SOC

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Refer to the master protocol (NCT04501978)

You may not qualify if:

  • Refer to the master protocol (NCT04501978)
  • Pregnant women
  • Nursing mothers
  • In addition, prior to the initial futility assessment which is performed when approximately 150 participants have been enrolled on BRII-196/BRII-198 and 150 on placebo, patients on high-flow oxygen or non-invasive ventilation (category 5 of the pulmonary ordinal outcome) will be excluded. These patients may be eligible for the trial if the initial futility assessment is passed by this agent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (107)

Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue

Tucson, Arizona, 85719, United States

Location

Southern Arizona VA Healthcare System (Site 074-009), 3601 S. 6th Ave.

Tucson, Arizona, 85723, United States

Location

Community Regional Medical Center (Site 203-005), 2823 Fresno Street

Fresno, California, 93701, United States

Location

VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street

Loma Linda, California, 92357, United States

Location

VA Long Beach Healthcare System (Site 074-026), 5901 East 7th Street (09/151-M2)

Long Beach, California, 90822, United States

Location

Keck Hospital of USC (Site 301-020), 1500 San Pablo Street

Los Angeles, California, 90033, United States

Location

Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Blvd.

Los Angeles, California, 90048, United States

Location

Ronald Reagan UCLA Medical Center (Site 203-002), 757 Westwood Plaza

Los Angeles, California, 90095, United States

Location

Hoag Memorial Hospital Presbyterian (Site 080-026), One Hoag Drive

Newport Beach, California, 92663, United States

Location

UCSF Medical Center at Mount Zion (Site 203-007), 1600 Divisadero St.

San Francisco, California, 94115, United States

Location

San Francisco VAMC (Site 074-002), 4150 Clement St.

San Francisco, California, 94121, United States

Location

UCSF Medical Center (Site 203-001), Moffitt-Long Hospital, 505 Parnassus Ave.

San Francisco, California, 94143, United States

Location

Stanford University Hospital & Clinics (Site 203-003), 300 Pasteur Dr.

Stanford, California, 94305, United States

Location

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (Site 066-002), 1124 W. Carson Street, CDCRC Building

Torrance, California, 90502, United States

Location

University of Colorado Hospital (Site 204-001), 12605 E. 16th Avenue

Aurora, Colorado, 80045, United States

Location

Denver Public Health (Site 017-004), 660 Bannock St., MC2600 (Infectious Disease Clinic)

Denver, Colorado, 80204, United States

Location

National Jewish Health / St. Joseph Hospital (Site 204-003), 1400 Jackson Street

Denver, Colorado, 80206, United States

Location

MedStar Georgetown University Hospital (Site 067-001), 3800 Reservoir Road NW

Washington D.C., District of Columbia, 20007, United States

Location

Washington DC VA Medical Center (Site 009-004), 50 Irving Street NW

Washington D.C., District of Columbia, 20422, United States

Location

Bay Pines VAMC (Site 074-004), 10000 Bay Pines Blvd., Bldg. 100, Room 5B-104

Bay Pines, Florida, 33744, United States

Location

Baycare Health System (Site 301-025), Morton Plant Hospital, 300 Pinellas Street

Clearwater, Florida, 33756, United States

Location

North Florida/South Georgia Veterans Health System (Site 074-011), 1601 SW. Archer Road

Gainesville, Florida, 32608-1197, United States

Location

Memorial Healthcare System (Site 648-002), Memorial Regional Hospital, 3501 Johnson Street

Hollywood, Florida, 33021, United States

Location

Miami VAMC (Site 074-003), 1201 NW 16 Street

Miami, Florida, 33125, United States

Location

Hillsborough County Health Department, University of South Florida (Site 032-001)

Tampa, Florida, 33602, United States

Location

Emory University (Site 301-008), The Emory Clinic, Bldg. A, Suite 2236, 1365 Clifton Rd., NE

Atlanta, Georgia, 30322, United States

Location

Lutheran Medical Group (Site 301-010), 7916 W. Jefferson Boulevard

Fort Wayne, Indiana, 46804, United States

Location

Cotton O'Neil Clinical Research Center (Site 080-030), Stormont Vail Health, 1500 SW 10th Avenue

Topeka, Kansas, 66604, United States

Location

University of Kentucky Hospital (Site 210-004), 1000 South Limestone St.

Lexington, Kentucky, 40536, United States

Location

Ochsner Clinic Foundation (Site 301-015), 1514 Jefferson Highway

New Orleans, Louisiana, 70121, United States

Location

University of Maryland Medical Center (Site 301-019), 22 South Greene Street

Baltimore, Maryland, 21201, United States

Location

Massachusetts General Hospital (Site 202-002), 55 Fruit Street

Boston, Massachusetts, 02114, United States

Location

Beth Israel Deaconess Medical Center (Site 202-001), 330 Brookline Ave.

Boston, Massachusetts, 02215, United States

Location

Baystate Medical Center (Site 201-001), 759 Chestnut Street

Springfield, Massachusetts, 01199, United States

Location

University of Michigan (Site 205-001), 1500 East Medical Center Drive

Ann Arbor, Michigan, 48109, United States

Location

Henry Ford Health System, Henry Ford Hospital (Site 014-001), 2799 W. Grand Blvd.

Detroit, Michigan, 48202, United States

Location

Minneapolis Heart Institute Foundation (Site 301-026), Abbott Northwestern Hospital, 920 E 28th St. #100

Minneapolis, Minnesota, 55407, United States

Location

Hennepin Healthcare (Site 027-001), 701 Park Avenue

Minneapolis, Minnesota, 55415, United States

Location

Minneapolis VA Health Care System (Site 105-001), 1 Veterans Drive, Bldg 70

Minneapolis, Minnesota, 55417, United States

Location

University of Mississippi Medical Center (Site 202-005), 2500 North State Street

Jackson, Mississippi, 39216, United States

Location

VA St. Louis Healthcare System (Site 074-027), 915 North Grand Blvd., Rm. C201

St Louis, Missouri, 63106, United States

Location

Dartmouth-Hitchcock Medical Center/Mary Hitchcock Memorial Hospital (Site 301-024), One Medical Center Drive

Lebanon, New Hampshire, 03756, United States

Location

Cooper University Hospital (Site 019-001), One Cooper Plaza

Camden, New Jersey, 08103, United States

Location

Ichan School of Medicine at Mount Sinai (Site 301-012), One Gustave L. Levy Place, Box 1620

New York, New York, 10029, United States

Location

Lincoln Medical Center (New York Health and Hospitals/Lincoln) (Site 003-016), 234 E. 149th Street

The Bronx, New York, 10451, United States

Location

Montefiore Medical Center Weiler Hospital (Site 206-003), 1825 Eastchester Road

The Bronx, New York, 10461, United States

Location

Montefiore Medical Center Moses Hospital (Site 206-001), 111 E. 210th Street

The Bronx, New York, 10467, United States

Location

Duke University Hospital (Site 301-006), 2301 Erwin Road

Durham, North Carolina, 27710, United States

Location

Wake Forest University Health Sciences (Site 210-001), Medical Center Blvd

Winston-Salem, North Carolina, 27157, United States

Location

University of Cincinnati Medical Center (Site 207-003), 234 Goodman Ave.

Cincinnati, Ohio, 45219, United States

Location

Cleveland Clinic Fairview Hospital (Site 207-005), 18101 Lorain Avenue

Cleveland, Ohio, 44111, United States

Location

Cleveland Clinic Foundation (Site 207-001), 9500 Euclid Avenue

Cleveland, Ohio, 44195, United States

Location

Cleveland Clinic Marymount Hospital (Site 207-006), 12300 McCraken Road

Garfield Heights, Ohio, 44125, United States

Location

Oregon Health & Science University (Site 208-003), 3181 SW Sam Jackson Park Rd.

Portland, Oregon, 97239-3098, United States

Location

UPMC Magee-Womens Hospital (Site 209-003), 300 Halket Street

Pittsburgh, Pennsylvania, 15213, United States

Location

UPMC Presbyterian Hospital (Site 209-001), 200 Lothrop Street

Pittsburgh, Pennsylvania, 15213, United States

Location

UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue

Pittsburgh, Pennsylvania, 15232, United States

Location

Rhode Island Hospital (Site 080-036), 593 Eddy Street

Providence, Rhode Island, 02903, United States

Location

The Miriam Hospital (Site 080-039), 164 Summit Ave.

Providence, Rhode Island, 02906, United States

Location

MUSC Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214

Charleston, South Carolina, 29425, United States

Location

VA TVHS Nashville Campus (Site 074-022), 1310 24th Avenue South

Nashville, Tennessee, 37212, United States

Location

Vanderbilt University Medical Center (Site 212-001), 1211 Medical Center Drive

Nashville, Tennessee, 37232, United States

Location

CHRISTUS Spohn Shoreline Hospital (Site 080-001), 600 Elizabeth Street

Corpus Christi, Texas, 78404, United States

Location

Parkland Health and Hospital Systems (Site 084-002), 5200 Harry Hines Blvd

Dallas, Texas, 75235, United States

Location

UT Southwestern Medical Center (Site 084-001), 1936 Amelia Court, 2nd Floor

Dallas, Texas, 75235, United States

Location

Baylor, Scott and White Health (Site 301-003), Baylor University Medical Center, 3500 Gaston Ave.

Dallas, Texas, 75246, United States

Location

Michael E. DeBakey Veterans Affairs Medical Center (MEDV AMC) (Site 074-006), 2002 Holcombe Blvd.

Houston, Texas, 77030, United States

Location

Texas Heart Institute (Site 301-017), 6770 Bertner, MC4-266

Houston, Texas, 77030, United States

Location

CHRISTUS Good Shepherd Medical Center (Site 080-031), 700 E. Marshall Ave.

Longview, Texas, 75601, United States

Location

Intermountain Medical Center (Site 211-001), 5121 South Cottonwood Street

Murray, Utah, 84107, United States

Location

University of Utah Hospital (Site 211-002), 419 Wakara Way, Suite 207

Salt Lake City, Utah, 84108, United States

Location

LDS Hospital (Site 211-004), 8th Ave. C Street

Salt Lake City, Utah, 84143, United States

Location

University of Virginia Health Systems (Site 301-021), 1215 Lee Street

Charlottesville, Virginia, 22903, United States

Location

Salem VA Medical Center (Site 074-014), 1970 Roanoke Blvd.

Salem, Virginia, 24153, United States

Location

Swedish Hospital First Hill (Site 208-005), 747 Broadway

Seattle, Washington, 98122, United States

Location

West Virginia University (Site 301-023), One Medical Center Drive

Morgantown, West Virginia, 26506, United States

Location

Aalborg Hospital (Site 625-005), Hobrovej 18

Aalborg, 9000, Denmark

Location

Aarhus Universitetshospital, Skejby (Site 625-002), Department of Infectious Diseases, Palle Juul-Hensens Boulevard 99

Aarhus N, 8200, Denmark

Location

Bispebjerg Hospital (Site 625-013), Bispebjerg Bakke 23

Copenhagen, 2400, Denmark

Location

Righospitalet (Site 625-006), Blegdamsvej 9,

Copenhagen Ø, 2100, Denmark

Location

Herlev/Gentofte Hospital (Site 625-012), Medicinsk Afdeling, Herlev Ringvej 75

Herlev, 2730, Denmark

Location

Nordsjællands Hospital (Site 625-009), Dyrehavevej 29

Hillerød, 3400, Denmark

Location

Hvidovre University Hospital, Department of Infectious Diseases (Site 625-001), Kettegård allé 30

Hvidovre, 2650, Denmark

Location

Kolding Sygehus (Site 625-011), Medicinsk Afdeling, Sygehusvej 24

Kolding, 6000, Denmark

Location

Odense University Hospital (Site 625-004), Infektionsmedicinsk Forskningsenhed, J.B. Winsløwsgade 4

Odense, 5000, Denmark

Location

Zealand University Hospital, Roskilde (Site 625-010), Sygehusvej 10

Roskilde, 4000, Denmark

Location

Wojewódzki Szpital Zakazny (Site 625-302), Wolska 37

Warsaw, 01-201, Poland

Location

Tan Tock Seng Hospital (Site 612-201), National Centre for Infectious Diseases (NCID), 11 Jalan Tan Tock Seng

Singapore, 308433, Singapore

Location

Hospital Universitari Germans Trias i Pujol (Site 626-003), Infectious Disease Unit, Second Floor, Building Maternal, Road Canyet s/n

Badalona, Barcelona, 08916, Spain

Location

Hospital Universitari Arnau de Vilanova (Site 626-035), Av. Alcalde Rovira Roure 80

Lleida, Leida, 25198, Spain

Location

Hospital Del Mar (Site 626-025), Paseo Maritimo 25-29

Barcelona, 08003, Spain

Location

Hospital Universitari Vall d'Hebron (Site 626-033), Passeig de la Vall d'Hebron 119-129

Barcelona, 08035, Spain

Location

Hospital Clínic de Barcelona (Site 626-004), Carrer de Villaroel 170

Barcelona, 08036, Spain

Location

Hospital Universitario de Bellvitge (Site 626-034), Carrer de la Feixa Llarga, s/n

Barcelona, 08907, Spain

Location

Hospital General Universitario Gregorio Marañón (Site 626-001), Dr. Esquerdo, 46

Madrid, 28017, Spain

Location

Hospital Clínico San Carlos (Site 626-017), Enfermedades infecciosas, C/Martin Lagos CN

Madrid, 28040, Spain

Location

UCICEC (Clinical Trial Unit) Hospital Universitario La Paz (Site 626-012), Paseo de la Castellana 261, 2a planta Hospital Maternal

Madrid, 28046, Spain

Location

University Hospital Zurich (Site 621-201), Department of Infectious Diseases and Hospital Epidemiology, Raemistrasse 100

Zurich, Canton of Zurich, 8091, Switzerland

Location

MRC/UVRI and LSHTM Uganda Research Unit (Site 634-601), Entebbe Regional Referral Hospital

Entebbe, Uganda

Location

Gulu Regional Referral Hospital (Site 634-603), Laroo Division, PO Box 160

Gulu, Uganda

Location

Makerere University Lung Institute (Site 634-604), New Mulago Hospital Complex, Mulago Hill

Kampala, Uganda

Location

St. Francis Hospital, Nsambya (Site 634-607), Nsambya Road Nsambya Hill, P.O. Box 7146

Kampala, Uganda

Location

Lira Regional Referral Hospital (Site 634-605)

Lira, Uganda

Location

Masaka Regional Referral Hospital (Site 634-606), MRC/UVRI and LSHTM Uganda Research Unit, Plot 6 Circle Road, PO Box 556

Masaka, Uganda

Location

Royal Victoria Infirmary (Site 634-007), Queen Victoria Road

Newcastle upon Tyne, Northumbria, NE1 4LP, United Kingdom

Location

Royal Free Hospital (Site 634-006), Pond Street, Hampstead

London, NW3 2QG, United Kingdom

Location

Guy's and St. Thomas' NHS Foundation Trust (Site 634-011)

London, SE1 7EH, United Kingdom

Location

Related Publications (1)

  • ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. Lancet Infect Dis. 2022 May;22(5):622-635. doi: 10.1016/S1473-3099(21)00751-9. Epub 2021 Dec 23.

MeSH Terms

Conditions

COVID-19Coronaviridae InfectionsCoronavirus InfectionsRNA Virus InfectionsVirus DiseasesNidovirales InfectionsSevere Acute Respiratory Syndrome

Interventions

amubarvimabromlusevimabremdesivir

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract Diseases

Results Point of Contact

Title
Greg Grandits
Organization
University of Minnesota

Study Officials

  • Jens Lundgren, Prof.

    INSIGHT Copenhagen International Coordinating Centre, Rigshospitalet, University of Copenhagen

    PRINCIPAL INVESTIGATOR
  • James Neaton, Prof.

    INSIGHT Statistical and Data Management Center, University of Minnesota

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2023

First Posted

March 22, 2023

Study Start

December 16, 2020

Primary Completion

June 8, 2021

Study Completion

October 10, 2022

Last Updated

February 5, 2024

Results First Posted

February 5, 2024

Record last verified: 2024-02

Locations